Rock Tech Lithium’s Progress Tally: Grant, Investment, and Cost Cuts Leave Stock Unmoved

Despite Ontario grant, CAD 200M BMI investment, and cost cuts, Rock Tech Lithium shares fell 8% to €0.53, 30% below 52-week high. Nasdaq listing and August feasibility study are key catalysts.

The disconnect between Rock Tech Lithium’s operational strides and its share price is growing. While the company notched fresh backing from Ontario’s government and a major Canadian investor in recent weeks, the stock has been drifting in the opposite direction. On Thursday, shares closed at €0.53, a loss of nearly 8% on the day and roughly 10% lower over the past month. That puts the equity more than 30% below its 52-week high of €0.79 touched in January, even though it still holds a year-to-date gain of approximately 13%.

Ontario has thrown its weight behind the junior miner for the second time in quick succession. The province’s Critical Minerals Innovation Fund is shelling out roughly CAD 262,000 for an experimental trial that uses crude tall oil — a by-product of the pulp and paper industry — as a flotation agent in lithium processing. If successful, the switch could lower both operational costs and emissions while creating a new revenue stream for the province’s forestry sector. The grant aligns with Ontario’s broader push to build clean battery supply chains.

On the corporate finance side, Rock Tech landed a CAD 200 million investment from the BMI Group for its planned Red Rock converter in Ontario. The deal includes non-dilutive upfront funding, a critical detail for current shareholders. Red Rock is targeting up to 32,000 tonnes of lithium carbonate equivalent per year, complementing the company’s flagship Guben project in Brandenburg, Germany. That facility, already fully permitted, is designed to produce 24,000 tonnes of battery-grade lithium hydroxide annually, with Mercedes-Benz locked in as a customer for 10,000 tonnes.

Cost discipline is becoming a central theme. Rock Tech recently said it expects to slash capital expenditure for Guben by an estimated €50 million and reduce operating costs by roughly 23%. In Canada, ore-sorting tests at the Georgia Lake project suggest upfront investment for the concentrator could be cut by as much as 50%. The definitive feasibility study for Georgia Lake is scheduled for August 2026, with a final investment decision due in the first quarter of 2027. Analysts have taken note: Simon Scholes at First Berlin Equity Research reiterated his buy rating and raised his price target sharply to CAD 3.90 from CAD 2.40, citing the accelerated pace at Red Rock.

To boost liquidity and broaden its investor base, Rock Tech is pressing ahead with a secondary listing on the Nasdaq. Preliminary documents have already been filed with Canadian regulators. The hope is that greater visibility and deeper analyst coverage will help close the valuation gap, though the reception from US capital markets remains uncertain.

The stock’s recent weakness has pushed it below its 50-day moving average of €0.58 — a technical level that, if reclaimed, would brighten the chart outlook. Traders are now looking toward the upcoming feasibility study due in August as a potential catalyst. The company’s annualised volatility over the past 30 days has run close to 50%, underscoring the nervousness that accompanies any junior miner’s journey from permit to production. Whether the Guben final investment decision or the Georgia Lake study can reignite momentum will depend on the market’s willingness to look past today’s financing gap and focus on the supply chains Europe and North America are racing to build.